progression-free survival
79 results
1 - 79
progression-free survival
trametinib- acalabrutinib
- PFS
- tebentafusp
- encorafenib
- osimertinib
- ensartinib
- margetuximab
- ripretinib
- amivantamab
- trabectedin
- mogamulizumab
- dacomitinib
- lazertinib
- tucatinib
- isatuximab
- fruquintinib
- datopotamab deruxtecan
- lutetium lu-177 vipivotide tetraxetan
- capivasertib
- durvalumab
- lutetium lu 177 dotatate
- tivozanib
- avelumab
- belzutifan
- olaparib
- cabozantinib
- lenalidomide
- gefitinib
- lanreotide
- polatuzumab vedotin
- ivosidenib
- abatacept
- riTUXimab
- obinutuzumab
- brigatinib
- ado-trastuzumab
- palbociclib
- idelalisib
- lenvatinib
- afatinib
- everolimus
- PAZOPanib
- dabrafenib
Prostate Cancer